A 19-year-old Canadian man becomes the first human cured through prime gene editing after doctors corrected a rare genetic ...

The prime editor is a fusion protein consisting of a catalytically impaired Cas9 nickase (Cas9n) and an engineered reverse transcriptase (RT). The Cas9n is guided by a prime editing guide RNA (pegRNA) ...

Prime Medicine's application will test an FDA that has promised to speed new gene-editing treatments but has recently spurned ...

Using prime editing, NCF1 mutation is corrected in a 19-year-old with chronic granulomatous disease, an inherited immune disorder, marking a gene therapy milestone.

The U.S. Food and Drug Administration approved the first cell-based gene therapies for sickle cell disease, including the ...

Add Yahoo as a preferred source to see more of our stories on Google. Prime Medicine will test its gene editing technology as treatment for a rare liver and lung disorder, revealing on Tuesday plans ...

Prime Medicine, a biotech company that set out to use its more precise approach to gene editing to develop new one-time treatments for rare diseases, is expanding its scope to more prevalent ...

In a recent study published in the Nature Biomedical Engineering, a group of researchers optimized prime editing (PE) for the efficient correction of the cystic fibrosis (CF) transmembrane conductance ...

Surface model of SpCas9–reverse transcriptase–pegRNA–target DNA complex. The prime editor, composed of a SpCas9 and a reverse transcriptase, reverse transcribes template sequence in pegRNA, resulting ...

Memories can live as remarkably cogent substances in the brain. It’s the definition of the word engram, which describes the physical content of how a memory is stored. But memories extend beyond the ...